Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/03/2009CA2721489A1 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality
12/03/2009CA2721065A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
12/03/2009CA2720531A1 Amide derivatives as positive allosteric modulators and methods of use thereof
12/03/2009CA2720310A1 Compositions for prevention/prophylactic treatment of poison ivy dermatitis
12/03/2009CA2719658A1 Compositions and methods for skin care
12/03/2009CA2719127A1 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof
12/03/2009CA2719125A1 Polysubstituted 2-aryl-6-phenyl-imidazo[l,2-a] pyridine derivatives, and preparation and therapeutic use thereof
12/03/2009CA2719118A1 Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2-a]pyridines, and preparation and therapeutic use thereof
12/03/2009CA2718953A1 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2-.alpha.] pyridines, and preparation and therapeutic use thereof
12/03/2009CA2718676A1 Divalent hydrazide compound conjugates for inhibiting cystic fibrosis transmembrane conductance regulator
12/03/2009CA2668245A1 Improved laxative composition and method
12/02/2009EP2128267A2 Methods of evaluating phosphatase inhibitors
12/02/2009EP2128265A1 Method for glycosylation of flavonoid
12/02/2009EP2128256A2 Molecular clones with mutated HIV GAG/POL, SIV GAG and SIV ENV genes
12/02/2009EP2128248A1 Oligonucleotide compositions with enhanced efficiency
12/02/2009EP2128171A1 Agent for prevention or treatment of iron overload
12/02/2009EP2128163A1 Spiro-ring compound
12/02/2009EP2128162A1 Novel crystal of piperacillin sodium
12/02/2009EP2128160A1 Indolo[2,3-b]-, Indeno[1,2-b]- and Indeno[2,1-b]pyrido[2,3-f] quinoxaline-3-carboxylic acids and esters, processes for their preparation and their use as antiviral, antibiotic and antitumor agents
12/02/2009EP2128158A1 Heterocyclic cyclopropyl-substituted FXR binding compounds
12/02/2009EP2128157A1 Heterocyclidene-n-(aryl)acetamide derivative
12/02/2009EP2128156A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibiting activity
12/02/2009EP2128155A1 Triazole derivative or salt thereof
12/02/2009EP2128154A1 Benzimidazole compound and pharmaceutical use thereof
12/02/2009EP2128148A1 Compound, alpha 1 adrenaline receptor antagonist, and composition
12/02/2009EP2128145A2 Improved method for synthesizing lamotrigine
12/02/2009EP2128138A1 Pyrazole compound
12/02/2009EP2128137A1 Selective m4 receptor antagonist and its medical use
12/02/2009EP2128136A1 2-phenylnicotinic acid derivative
12/02/2009EP2128134A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13
12/02/2009EP2128125A1 Caffeoyl quinic acid derivatives containing nitrogen, and preparation method, pharmaceutically composition and usage thereof
12/02/2009EP2128123A1 Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof
12/02/2009EP2127681A1 Therapeutic agent for periodontal disease and alveolar bone loss due to surgery
12/02/2009EP2127676A2 Treatment of obesity and related disorders
12/02/2009EP2127675A1 Antiviral agent
12/02/2009EP2127673A1 Pharmaceutical agent for prevention and treatment of skin disease induced by accelerated keratinization
12/02/2009EP2127667A1 Oral disinfectant, food additive comprising the disinfectant
12/02/2009EP2127661A1 Probiotics to improve gut microbiotica
12/02/2009EP2127659A1 Use of high osmotic liquid composition in manufacturing medicament for enhancing wound healing
12/02/2009EP2127658A1 Therapeutic agent for meniere s disease
12/02/2009EP2127656A1 Compositions of risedronate and vitamin d3
12/02/2009EP2127655A1 Use of loteprednol etabonate for the treatment of dry eye
12/02/2009EP2127654A1 Benzothiazepine derivatives as ryanodine receptor (RYR2) inhibitors and their use in the treatment of cardiac diseases
12/02/2009EP2127653A1 Agent for treatment of multiple sclerosis
12/02/2009EP2127652A1 Method for treating cancer using anticancer agent in combination
12/02/2009EP2127651A1 Stabilized medicinal composition containing donepezil, method of producing the same and method for stabilization
12/02/2009EP2127650A2 Carbapenem antibacterials with gram-negative activity and processes for their preparation
12/02/2009EP2127649A1 Composition for promoting bioabsorption of flavonoid, food/beverage for promoting bioabsorption of flavonoid using the composition, and method for production of the food/beverage
12/02/2009EP2127648A1 Pharmaceutical formulations of amyloid inhibiting compounds
12/02/2009EP2127647A1 Composition for inhibiting muscle damage
12/02/2009EP2127646A1 Agent for relief or prevention of xerostomia
12/02/2009EP2127645A1 Pharmaceutical agent for prevention and/or treatment of lower urinary tract symptom
12/02/2009EP2127643A1 Oral pellet composition with time-delayed release
12/02/2009EP2127642A2 Microemulsions as solid dosage forms for oral administration
12/02/2009EP2127641A1 Micronisable form of salmeterol xinafoate
12/02/2009EP2127639A1 Corticosteroid containing liposomes for treatment of cardiovascular diseases
12/02/2009EP2127638A1 Method and composition for treating ocular hypertension and glaucoma
12/02/2009EP2127636A1 Anti-wrinkle agent and adam inhibitor
12/02/2009EP2127520A1 Gel-like sterilizing/disinfecting composition
12/02/2009EP2126127A2 Use of anti-egfr antibodies in treatment of egfr mutant mediated disease
12/02/2009EP2126085A2 Nucleic acid compounds for inhibiting myc gene expression and uses thereof
12/02/2009EP2126082A1 Nucleic acid compounds for inhibiting bcl2 gene expression and uses thereof
12/02/2009EP2126081A2 Nucleic acid compounds for inhibiting hif1a gene expression and uses thereof
12/02/2009EP2125859A2 Estratriene derivatives and their uses as 17beta-hydroxysteroid dehydrogenase inhibitors
12/02/2009EP2125858A2 Pharmaceutically acceptable salts of 11-(4-aminophenyl)-19-norpregna-4,9(10)-diene-3,20-dione derivatives
12/02/2009EP2125855A2 Methods and compositions for the treatment of cancer or other diseases
12/02/2009EP2125851A2 Erythromycin-based macrolides
12/02/2009EP2125849A1 Sulfoglycolipid antigens, their process of preparation, and their use against tuberculosis
12/02/2009EP2125848A1 Antiviral compounds
12/02/2009EP2125841A1 Monophosphates as mutual prodrugs of anti-inflammatory signal transduction modulators (aistm's) and beta-agonists for the treatment of pulmonary inflammation and bronchoconstriction
12/02/2009EP2125831A1 Oxazinyl isoflavonoid compounds, medicaments and use
12/02/2009EP2125828A2 Thieno pyrimidine compounds
12/02/2009EP2125818A1 New classical antifolates
12/02/2009EP2125817A1 7-(3',4'-dialkoxyphenyl)-[1,2,4]-triazolo[1,5-a]pyrimidine compounds, process for preparing thereof, and pharmaceutical composition for treating or preventing asthma, chronic obstructive pulmonary disease, arthritis, atopic dermatitis, tumor and degenerative brain diseases comprising the same
12/02/2009EP2125816A2 Metalloprotease inhibitors containing a heterocyclic moiety
12/02/2009EP2125809A1 Imidazopyridine inhibitors of iap
12/02/2009EP2125807A2 Imidazo[1,2-a]pyrrolo[3,2-c]pyridine compounds useful as pestivirus inhibitors
12/02/2009EP2125804A1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoý4,5-b¨pyridin-2-one derivatives useful as a2b adenosine receptor antagonists
12/02/2009EP2125801A1 The use of 7-azaindoles in the inhibition of c-jun n-terminal kinase
12/02/2009EP2125797A1 Amino- pyridine derivatives as s1p1 /edg1 receptor agonists
12/02/2009EP2125787A1 Derivatives of n-(heteroaryl)-1-heteroaryl-1h-indol-2-carboxamids, preparation thereof and therapeutic use thereof
12/02/2009EP2125785A1 Indoles
12/02/2009EP2125783A2 Process for the preparation of esomeprazole magnesium dihydrate
12/02/2009EP2125779A1 Polymorphs of a mglur5 receptor antagonist
12/02/2009EP2125777A1 Spiro substituted compounds as angiogenesis inhibitors
12/02/2009EP2125776A1 Spiro substituted compounds as angiogenesis inhibitors
12/02/2009EP2125775A1 Antioxidant polymers containing [1,2]-dithiolane moieties and uses thereof
12/02/2009EP2125773A1 Thiophene derivatives useful as medicaments for treating ocular hypertension
12/02/2009EP2125769A2 Steroids derivatives as selective progesterone receptor modulators
12/02/2009EP2125768A1 Tetrasubstituted glucopyranosylated benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
12/02/2009EP2125756A1 Phenazine compounds and use thereof in autoimmune and inflammatory diseases
12/02/2009EP2125753A1 Fused heterocyclic compounds having crf antagonistic activity
12/02/2009EP2125750A2 Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/02/2009EP2125747A1 1,5-diaryl-pyrazoles as cannabinoid receptor neutral antagonists useful as therapeutic agents
12/02/2009EP2125745A1 Cycloalkylamine substituted isoquinolone derivatives
12/02/2009EP2125744A1 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives
12/02/2009EP2125738A1 Immune response modifier compositions and methods
12/02/2009EP2125731A1 Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases
12/02/2009EP2125728A1 Novel combination of compounds to be used in the treatment of airway diseases, especially chronic obstructive pulmonary disease (copd) and asthma
12/02/2009EP2125727A1 Stable s-nitrosothiols, method of synthesis and use
1 ... 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 ... 7860